COMMUNIQUÉS West-GlobeNewswire

‘Sleep Normal’ campaign urges Americans to end frequent nighttime urination and stop settling for nights of bad sleep

23/01/2019 - 16:30

Nearly 50 million Americans wake up to urinate more than once per night due to a treatable medical condition called nocturia WASHINGTON, Jan. 23, 2019 (GLOBE NEWSWIRE) -- A new awareness campaign called ‘Sleep Normal’ [...]

Selecta Biosciences Announces Pricing of Public Offering of Common Stock

23/01/2019 - 15:19

WATERTOWN, Mass., Jan. 23, 2019 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (Nasdaq: SELB) (“Selecta”), a clinical-stage biotechnology company focused on unlocking the full potential of biologic therapies based on its [...]

eSight Corp. Appoints Kevin Banderk to Chief Commercial Officer

23/01/2019 - 15:11

TORONTO, Jan. 23, 2019 (GLOBE NEWSWIRE) -- eSight , creators of the world's most advanced sight-enhancing glasses for the visually impaired, is pleased to announce the appointment of Kevin Banderk to the position of [...]

Long-term survival analysis of the randomised Phase III study shows a clear clinical benefit of inolimomab in SR-aGvHD

23/01/2019 - 15:00

Long-term survival analysis of the randomised Phase III study shows a clear clinical benefit of inolimomab in SR-aGvHD Follow-up of INO-107 Phase III study patients up to 8.5 years is the first long term analysis of a [...]

L’analyse de survie à long terme de l’étude de phase III randomisée démontre un bénéfice clinique évident de l’inolimomab dans le traitement de la SR-aGvHD

23/01/2019 - 15:00

L’analyse de survie à long terme de l’étude de phase III randomisée démontre un bénéfice clinique évident de l’inolimomab dans le traitement de la SR-aGvHD Le suivi des patients de l’étude de phase III INO-107 jusqu’à 8 [...]

Rexahn Announces Pricing of Public Offering of Common Stock and Warrants

23/01/2019 - 15:00

ROCKVILLE, Md., Jan. 23, 2019 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN) today announced the pricing of an underwritten public offering of 10,750,000 shares of its common stock and warrants to [...]

HealthEquity to Announce Year-End HSAs and Custodial Assets

23/01/2019 - 15:00

DRAPER, Utah, Jan. 23, 2019 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the nation’s largest HSA non-bank custodian, today announced that it plans to release its fiscal year- [...]

Generex Announces REVISED Record Date for NuGenerex Immuno-Oncology Stock Dividend

23/01/2019 - 15:00

MIRAMAR, FL , Jan. 23, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) ( http://www.otcmarkets.com/stock/GNBT/quote ) today announced that it has REVISED [...]

Auris Medical Announces Publication of New Data Highlighting the Role of Betahistine in Promoting the Restoration of Forgotten Memories in Mice and Healthy Volunteers

23/01/2019 - 14:31

Zug, Switzerland, January 23, 2019 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous [...]

Aurora Spine Announces New Patent for Its Minimally Invasive Spinal Implants Allowed by the United States Patent Office

23/01/2019 - 14:30

CARLSBAD, Calif., Jan. 23, 2019 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (TSXV: ASG) announced today the issuance by the United States Patent and Trademark Office (USPTO) of United States Patent No. 10,143,501 [...]

Nextech Acquires SRS Health, a Specialty EMR Solution for Orthopedic Practices

23/01/2019 - 14:30

Nextech completes acquisition of SRS and expands portfolio to include orthopedic specialty solutions TAMPA, Fla., Jan. 23, 2019 (GLOBE NEWSWIRE) -- Nextech Systems , a leading provider of healthcare technology solutions [...]

Daxor Corporation Appoints Guido Manzo, Vice President of Sales

23/01/2019 - 14:30

NEW YORK, Jan. 23, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) , an innovative medical instrumentation and biotechnology company focused on blood volume measurement today announces the appointment of [...]

Ritter Pharmaceuticals To Present at Noble Capital Markets’ Fifteenth Annual Investor/Equity Conference on January 28, 2019

23/01/2019 - 14:30

LOS ANGELES, Jan. 23, 2019 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of innovative therapeutic products that modulate the gut microbiome to [...]

Imagin Medical to Present at Noble Capital Markets’ 15th Annual Investor Conference

23/01/2019 - 14:30

VANCOUVER, British Columbia and BOSTON, Jan. 23, 2019 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”), an emerging leader in the [...]

MyoKardia Appoints William Fairey as Chief Commercial Officer

23/01/2019 - 14:30

SOUTH SAN FRANCISCO, Calif., Jan. 23, 2019 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable [...]

Bermekimab Successfully Treats Hidradenitis Suppurativa, Including Significant Reduction in Pain

23/01/2019 - 14:30

Bermekimab Treats HS Patients Even After Failure with Leading Biological Therapy AUSTIN, Texas, Jan. 23, 2019 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ: XBIT) announced today the successful outcome of its multicenter, open [...]

Attune Pharmaceuticals Announces $23M Series B Financing to Advance ATN-249 for the Treatment of HAE

23/01/2019 - 14:06

NEW YORK, Jan. 23, 2019 (GLOBE NEWSWIRE) -- Attune Pharmaceuticals, Inc., a biotechnology company focused on the discovery and development of novel, orally-administered, small molecule therapeutics for the treatment of [...]

Biocartis Group NV: BIOCARTIS LAUNCHES EQUITY PLACEMENT

23/01/2019 - 14:01

THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE PROHIBITED BY APPLICABLE LAW [...]

Foamix Announces Appointment of Sharon Barbari to Board of Directors

23/01/2019 - 14:00

REHOVOT, Israel, and BRIDGEWATER, N.J., Jan. 23, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX), a clinical stage specialty pharmaceutical company focused on developing and commercializing [...]